Issue link: https://www.e-digitaleditions.com/i/1546950
Inhalation OctOber 2026 7 should sign up now for maxi- mum visibility. • Integrated poster and exhibi- tion sessions for the duration of the conference. Poster abstract submission deadline: January 15, 2027. • Attend delegate-selectable work- shops providing practical and interactive demonstrations of innovative technologies, prod- ucts and services. • e VCU RDD Peter R. Byron Graduate Student Award. Eligi- bility is automatic upon accep- tance of a qualifying poster abstract. RDD has a long history of bring- ing the pulmonary and nasal drug delivery community together with substance and style. We invite you to be a part of it by actively planning to participate in RDD Europe 2027 next April. • Soft-Mist Inhalers & Nebuliz- ers: Breakthroughs in aqueous- based device technologies. • Inhalation Innovation: Cross- platform advances in regulatory science, connectivity and digi- tal health, modeling, advanced data analytics, sustainability and other emerging topics. In response to feedback requesting more inclusion of early stage pul- monary and nasal research from biotech, start-ups and entrepre- neurs, the Program Committee welcomes proposals and speaker suggestions highlighting Rising Stars in Respiratory Science. RDD Europe 2027 Deadlines and details ere are numerous ways to par- ticipate. More details and submis- sion links are available at www. rddonline.com/rddeurope2027. • Early-bird and waived graduate student registration to eligible students. • Conference supporters, work- shop presenters and exhibitors Extended online access to RDD 2026 Delegates who struggled to see all the content during the conference have on-demand access to presen- tations, posters and workshops until December 31, 2026. RDD 2026 delegates and subscribers can use their existing log-in credentials to access the RDD Publications database of over 3,100 papers cov- ering 38 years of pulmonary and nasal drug development (www. rddonline.com/publications). Our sincere thanks to all dele- gates, presenters, sponsors, media partners, reviewers, moderators and helpers at RDD 2026. RDD Europe 2027: Plan to participate RDD Europe 2027 will be held at the Palais des Congrès Antipo- lis Antibes (Nice), France, April 27-30, 2027. It's an easily acces- sible venue with plenty of accom- modation options nearby. e three-day format will have almost all the features described above with the emphasis on pioneering science and opportunities for net- working in a collegial and business- friendly setting. e program will be built around invited presentations in each key area covered by the RDD Confer- ence series. Specifically: • Bench to Bedside: New therapeu- tic targets, emerging therapies including biotherapeutics, diag- nostics and clinical approaches to improve pulmonary health for patient populations. • Pressurized Inhalers: Progress in alternative propellants and for- mulations, hardware, environ- mental impact. • Dry Powder Inhalers: Advances in pharmaceutical engineer- ing, formulation science, device design and industrialization. • Nasal Delivery: Intranasal plat- forms for local, systemic and nose to brain delivery.

